Kymab - Crunchbase Company Profile & Funding

Kymab may be growing as it was acquired by Sanofi for up to $1.5 billion, which is a significant financial transaction indicating a valuation growth. The acquisition by a major pharmaceutical …


Install CouponFollow Chrome Extension   CouponFollow Extension

$1
OFF

Kymab - Crunchbase Company Profile & Funding

2 weeks from now

Kymab may be growing as it was acquired by Sanofi for up to $1.5 billion, which is a significant financial transaction indicating a valuation growth. The acquisition by a major pharmaceutical …

crunchbase.com

$40000000
OFF

Series B - Kymab - 2014-05-16 - Crunchbase Funding Round Profile

2 weeks from now

Kymab raised $40000000 on 2014-05-16 in Series B. Search Crunchbase. Start Free Trial . Chrome Extension ... Edit Overview Section. Organization Name . Kymab . Announced Date …

crunchbase.com

$348
OFF

Kymab - Raised $348M Funding From 14 Investors - Tracxn

2 weeks from now

Dec 1, 2024  · Kymab has raised a total funding of $348M over 8 rounds from 14 investors. Investors include Bill & Melinda Gates Foundation', Woodford Investment Management and 12 …

tracxn.com

$209
OFF

Kymab Stock Price, Funding, Valuation, Revenue & Financial …

2 weeks from now

Jan 11, 2021  · Funding, Valuation & Revenue. 8 Fundings. Kymab has raised $209M over 8 rounds.. Kymab's latest funding round was a Acquired for on January 11, 2021.. Kymab's …

cbinsights.com

$348
OFF

Kymab - Company Profile - Tracxn

2 weeks from now

Dec 1, 2024  · Kymab - Provider of monoclonal antibody therapeutics for multiple diseases. Acquired by Sanofi. Raised a total funding of $348M over 8 rounds from 14 investors. Valued …

tracxn.com

$40
OFF

Kymab Lands $40M In Series B Funding - PitchBook

2 weeks from now

Kymab, a monoclonal antibody biopharmaceutical company, has raised $40 million in a Series B financing round. Bill & Melinda Gates Foundation joined existing investor Wellcome Trust in …

pitchbook.com

$70
OFF

Kymab: One Multi-Award Winning Biotech Company Worth …

2 weeks from now

Sep 9, 2015  · With a combined $70M (€63M) in equity funding from both the Bill & Melinda Gates Foundation and the Wellcome Trust, Kymab has very strong financial backing. Other equity …

labiotech.eu

$50000000
OFF

Series B - Kymab - 2015-05-06 - Crunchbase Funding Round Profile

2 weeks from now

Kymab raised $50000000 on 2015-05-06 in Series B. Start Free Trial . Chrome Extension

crunchbase.com

$220
OFF

Kymab Company Profile - Office Locations, Competitors, Revenue …

2 weeks from now

Kymab has 5 employees across 2 locations and $220.4 m in total funding,. See insights on Kymab including office locations, competitors, revenue, financials, executives, subsidiaries …

craft.co

$9000000
OFF

Grant - Kymab - 2017-01-10 - Crunchbase Funding Round Profile

2 weeks from now

Kymab raised $9000000 on 2017-01-10 in Grant. Start Free Trial . Chrome Extension

crunchbase.com

$125
OFF

AMP - Crunchbase Company Profile & Funding

2 weeks from now

Edit Lists Featuring This Company Section United States Electric Vehicle Companies 1,265 Number of Organizations • $125.5B Total Funding Amount • 1,979 Number of Investors

crunchbase.com

FAQs about Kymab - Crunchbase Company Profile & Funding Coupon?

How many investors does kymab have?

Kymab has 6 investors including Bill & Melinda Gates Foundation and Malin Corporation. How much funding has Kymab raised to date? Kymab has raised ...

Where is kymab located?

Kymab is located in Cambridge, Cambridgeshire, United Kingdom. Who invested in Kymab? Kymab has 6 investors including Bill & Melinda Gates Foundation and Malin Corporation. How much funding has Kymab raised to date? ...

Who is kymab?

Kymab is a clinical-stage biopharmaceutical company developing fully human monoclonal antibody therapeutics. View contacts for Kymab to access new leads and connect with decision-makers. ...

Who bought kymab?

Kymab was acquired by Sanofi for $1.1B on Jan 11, 2021. Where is Kymab's headquarters? Kymab is located in Cambridge, Cambridgeshire, United Kingdom. ...

Who founded Kymab?

Kymab was founded by Professor Allan Bradley, FRS, in 2010 based on developments in his laboratory at the Wellcome Sanger Institute. The company has raised $30m of equity financing from the Wellcome Trust Investment Division, which has enabled the development of the KymouseTM platform and the creation of a portfolio of therapeutic assets. ...

When did kymab close?

Kymab closed its last funding round on Jan 10, 2017 from a Grant round. Who are Kymab's competitors? Alternatives and possible competitors to Kymab may include CureVac , Aclaris Therapeutics , and Innovent Biologics. ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension